These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 32472577)
1. Alternatives to amyloid for Alzheimer's disease therapies-a symposium report. Cable J; Holtzman DM; Hyman BT; Tansey MG; Colonna M; Kellis M; Brinton RD; Albert M; Wellington CL; Sisodia SS; Tanzi RE Ann N Y Acad Sci; 2020 Sep; 1475(1):3-14. PubMed ID: 32472577 [TBL] [Abstract][Full Text] [Related]
2. Editorial: Targets for Disease-Modifying Therapies in Alzheimer's Disease, Including Amyloid β and Tau Protein. Parums DV Med Sci Monit; 2021 Jul; 27():e934077. PubMed ID: 34305135 [TBL] [Abstract][Full Text] [Related]
3. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles. Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003 [TBL] [Abstract][Full Text] [Related]
4. Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives. Imbimbo BP; Lozupone M; Watling M; Panza F Expert Opin Investig Drugs; 2020 Sep; 29(9):919-933. PubMed ID: 32657175 [TBL] [Abstract][Full Text] [Related]
5. Time to test antibacterial therapy in Alzheimer's disease. Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495 [TBL] [Abstract][Full Text] [Related]
6. Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease. Tamburini B; Badami GD; La Manna MP; Shekarkar Azgomi M; Caccamo N; Dieli F Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569296 [TBL] [Abstract][Full Text] [Related]
7. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease. Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164 [TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease. Nagu P; Parashar A; Behl T; Mehta V J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Mullane K; Williams M Biochem Pharmacol; 2020 Jul; 177():113945. PubMed ID: 32247851 [TBL] [Abstract][Full Text] [Related]
10. Status and future directions of clinical trials in Alzheimer's disease. Plascencia-Villa G; Perry G Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008 [TBL] [Abstract][Full Text] [Related]
11. Microglia in Alzheimer's Disease in the Context of Tau Pathology. Perea JR; Bolós M; Avila J Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066368 [TBL] [Abstract][Full Text] [Related]
12. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology. Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684 [TBL] [Abstract][Full Text] [Related]
14. Emerging amyloid and tau targeting treatments for Alzheimer's disease. Khan A; Corbett A; Ballard C Expert Rev Neurother; 2017 Jul; 17(7):697-711. PubMed ID: 28490214 [TBL] [Abstract][Full Text] [Related]
15. Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere? Imbimbo BP; Ippati S; Watling M Expert Opin Drug Discov; 2020 Nov; 15(11):1241-1251. PubMed ID: 32686970 [TBL] [Abstract][Full Text] [Related]